Keiko Baba
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Prophylactic effect of ensitrelvir in mice infected with SARS-CoV-2.
Journal: Antiviral research
Published: November 29, 2023
A Randomized Phase 2/3 Study of Ensitrelvir, a Novel Oral SARS-CoV-2 3C-Like Protease Inhibitor, in Japanese Patients with Mild-to-Moderate COVID-19 or Asymptomatic SARS-CoV-2 Infection: Results of the Phase 2a Part.
Journal: Antimicrobial agents and chemotherapy
Published: September 13, 2022
Efficacy and Safety of Ensitrelvir in Patients With Mild-to-Moderate Coronavirus Disease 2019: The Phase 2b Part of a Randomized, Placebo-Controlled, Phase 2/3 Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 11, 2022
Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model.
Journal: Communications biology
Published: May 05, 2022
Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model.
Journal: PLoS pathogens
Published: October 16, 2020
Comprehensive assessment of amino acid substitutions in the trimeric RNA polymerase complex of influenza A virus detected in clinical trials of baloxavir marboxil.
Journal: Influenza and other respiratory viruses
Published: June 19, 2020
Carryover effects of baloxavir acid in human nasopharyngeal/pharyngeal swabs on infectious titer testing of influenza virus.
Journal: Influenza and other respiratory viruses
Published: September 03, 2019
Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 08, 2019
Treatment-Emergent Influenza Variant Viruses With Reduced Baloxavir Susceptibility: Impact on Clinical and Virologic Outcomes in Uncomplicated Influenza.
Journal: The Journal of infectious diseases
Published: January 12, 2019
In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Journal: Antiviral research
Published: June 07, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026